Lymphoma, Non-Hodgkin
Item
diagnosis of non-hodgkin's lymphoma
boolean
C0024305 (UMLS CUI [1])
Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging
Item
measurable disease by ct scan or nuclear medicine imaging
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0034606 (UMLS CUI [2,2])
Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan
Item
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
boolean
C2936643 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1260363 (UMLS CUI [2])
C1134535 (UMLS CUI [3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix
Item
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0851140 (UMLS CUI [4])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Chronic Alcoholic Intoxication Absent | Drug abuse Absent
Item
no alcoholism or drug abuse within the past 2 years
boolean
C0001973 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited
Item
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
boolean
C0677660 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0233514 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C1306597 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0848067 (UMLS CUI [4,1])
C0525058 (UMLS CUI [4,2])
C0439801 (UMLS CUI [4,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Study Subject Participation Status Exclusion | Investigational New Drugs Absent
Item
no concurrent participation in another investigational drug study
boolean
C2348568 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])